Comparison of postoperative adjuvant therapy and surgery alone in pathological N1-2 esophageal squamous cell carcinoma: A prospective multi-center randomized controlled trial. This is an ASCO Meeting ...
Whole brain radiotherapy and intrathecal injection of thiotepa, combined with systemic treatment for the primary tumor, to treat solid tumor leptomeningeal metastasis: A prospective, single center, ...
The Hearty Soul on MSN
Scientists Discover Key Cells That Prevent Your Immune System from Attacking Itself
Every day, your immune system performs a delicate balancing act, attacking harmful invaders while protecting your own tissues ...
(PFS) of 50% in the higher 15 mg/kg dose cohort compares favorably to historical PD-(L)1 refractory settings – All clinical responses, including a complete response, observed in the higher 15 mg/kg ...
Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering precision immunotherapies for oncology and inflammation & immunology (I&I), today presented the first disclosure of ...
CStone Pharmaceuticals (CStone, HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and ...
Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...
The poster for INSIGHT-003 and the Trial in Progress ePoster for TACTI-004 can be found at the Posters & Publications section of Immutep’s website.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback